Adderall [Bioanalytics]

posted by jag009  – NJ, 2012-05-22 23:31 (5149 d 17:31 ago) – Posting: # 8607
Views: 3,793

Hi Everyone,

As per FDA, BE studies for Mixed Amphetamine (Adderall, Adderall XR) requires measurement of both D- and L-amphetamine in the plasma. What about the requirement of 5% difference in relative potency (total Assay) between test and reference product? Does one have to demonstrate that on both D and L forms of amphetamine?

Thanks

John

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
379 visitors (0 registered, 379 guests [including 13 identified bots]).
Forum time: 17:02 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5